Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 225.00
-3.97 (-1.73%)
Apr 6, 2026, 3:29 PM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 2.88 billion as of April 6, 2026. Its market cap has decreased by -45.12% in one year.
Market Cap
2.88B
Enterprise Value
2.83B
Revenue
1.72B
Ranking
n/a
PE Ratio
37.12
Stock Price
225.00
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 2.88B, an increase of 2,556.86%. That is a compound annual growth rate of 16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.94B | -36.41% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 12.47B |
| Ind-Swift Laboratories | 12.04B |
| Sakar Healthcare | 11.47B |
| Sigachi Industries | 7.39B |
| Valiant Laboratories | 3.11B |
| Bafna Pharmaceuticals | 2.63B |
| Nectar Lifesciences | 1.95B |
| Brooks Laboratories | 1.57B |